Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
148M
-
Number of holders
-
192
-
Total 13F shares, excl. options
-
154M
-
Shares change
-
-6.69M
-
Total reported value, excl. options
-
$2.27B
-
Value change
-
-$3.42M
-
Put/Call ratio
-
8.68
-
Number of buys
-
110
-
Number of sells
-
-103
-
Price
-
$14.70
Significant Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q3 2025
267 filings reported holding ETNB - 89bio, Inc. - Common stock, par value $0.001 per share as of Q3 2025.
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) has 192 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 154M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (19.9M shares), Pentwater Capital Management LP (11.8M shares), BlackRock, Inc. (10.3M shares), Deep Track Capital, LP (9.36M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (9.1M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (8.28M shares), VANGUARD GROUP INC (8.05M shares), Avoro Capital Advisors LLC (6.39M shares), GLAZER CAPITAL, LLC (5.64M shares), and JANUS HENDERSON GROUP PLC (5.38M shares).
This table shows the top 192 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.